| Nombre del producto |
Saperconazole |
| Nombre en inglés |
Saperconazole;Saperconazole [USAN:INN:BAN]; (+-)-1-sec-Butyl-4-(p-(4-(p-(((2R*,4S*)-2-(2,4-difluorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl)methoxy)phenyl)-1-piperazinyl)phenyl)-delta(sup 2)-1,2,4-triazolin-5-one; 3H-1,2,4-Triazol-3-one, 4-(4-(4-(4-((2-(2,4-difluorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl)methoxy)phenyl)-1-piperazinyl)phenyl)-2,4-dihydro-2-(1-methylpropyl)-; R66905; Saperconazol; Saperconazol [INN-Spanish]; Saperconazolum; Saperconazolum [INN-Latin]; 2-(butan-2-yl)-4-{4-[4-(4-{[(2S,4R)-2-(2,4-difluorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-2,4-dihydro-3H-1,2,4-triazol-3-one; 2-(butan-2-yl)-4-{4-[4-(4-{[(2R,4S)-2-(2,4-difluorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-2,4-dihydro-3H-1,2,4-triazol-3-one |
| Fórmula molecular |
C35H38F2N8O4 |
| Peso Molecular |
672.7242 |
| InChI |
InChI=1/C35H38F2N8O4/c1-3-25(2)45-34(46)44(24-40-45)29-7-5-27(6-8-29)41-14-16-42(17-15-41)28-9-11-30(12-10-28)47-19-31-20-48-35(49-31,21-43-23-38-22-39-43)32-13-4-26(36)18-33(32)37/h4-13,18,22-25,31H,3,14-17,19-21H2,1-2H3/t25?,31-,35-/m0/s1 |
| Número de registro CAS |
110588-57-3 |
| Estructura Molecular |
|
| Densidad |
1.37g/cm3 |
| Punto de ebullición |
812.5°C at 760 mmHg |
| Índice de refracción |
1.656 |
| Punto de inflamación |
445.2°C |
| Presión de vapor |
1.81E-26mmHg at 25°C |
| Símbolos de Peligro |
|
| Códigos de Riesgos |
|
| Descripción de Seguridad |
|
|
